Nanovaccine administration route is critical to obtain pertinent iNKt cell help for robust anti-tumor T and B cell responses

Nanovaccines, co-delivering antigen and invariant natural killer T (iNKT) cell agonists, proved to be very effective in inducing anti-tumor T cell responses due to their exceptional helper function. However, it is known that iNKT cells are not equally present in all lymphoid organs and nanoparticles...

Descripción completa

Detalles Bibliográficos
Autores principales: Dölen, Yusuf, Valente, Michael, Tagit, Oya, Jäger, Eliezer, Van Dinther, Eric A. W., van Riessen, N. Koen, Hruby, Martin, Gileadi, Uzi, Cerundolo, Vincenzo, Figdor, Carl G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Back Matter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790498/
https://www.ncbi.nlm.nih.gov/pubmed/33457086
http://dx.doi.org/10.1080/2162402X.2020.1738813

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790498/
https://www.ncbi.nlm.nih.gov/pubmed/33457086
http://dx.doi.org/10.1080/2162402X.2020.1738813

Ejemplares similares